
proCardio Asia Pacific


How to Manage PMI? – Practical Implementation in Ramathibodi Hospital

Lp(a) Screening at Least Once a Lifetime! Unwrapping the What, Why and How’s of Lipoprotein(a)

NT-proBNP as a predictor of Cardio-renal Complications in PwD

Safety of Rx Optimisation Post AHF Hospitalization

Practical Implementation of GDMT Optimisation – The ATP in NZ

Use of Rapid Algo for Suspected AMI – Faster Triage of ED Patients


Navigating Cardiotoxicity – Value of Cardiac Biomarkers


DROP Asian ACS – Study Results and Practical Approach


The Importance of Early Diagnosis and Management of AHF


Integrative Approaches to Managing Diabetes and Cardiovascular Disease


Optimising GDMT Post AHF Discharge – APAC APSC Consensus Highlights


Initiation of GDMT Therapy in Patients Discharged Post AHF – What are the Guardrails?


Enhancing Diabetes and Cardiovascular Management with Continuous Glucose Monitoring


New Frontiers for Risk Stratification Assays for Acute Coronary Syndrome – The Gen6 Assay for hs cTnT


NT-proBNP for Rapid Optimisation of GDMT in AHF Patients in Japan


STRONG-HF: Implementation of GDMT Heart Failure Therapy & Post-discharge Heart Failure Management


NT-proBNP and ECHO in heart failure – do they always go hand in hand?





















